Delivery Order SPE2DB24D3013-SPE2DB25FFQCW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,676.12 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-pack) on April 24, 2025, with completion expected by April 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract fulfills a critical medical supply need within the federal procurement system,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,177.50 on September 11, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.00 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Narcan 4 mg nasal spray (2-unit package) with a ceiling value of $11,069.04. This firm fixed-price delivery order is scheduled for completion by September 29, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this competitively awarded contract. This delivery...
- The Defense Logistics Agency awarded a $1,240.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (two-unit package) on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected to deliver this emergency...
- The Defense Logistics Agency awarded a $2,615.88 delivery order to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (2-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,143.28 for Narcan 4 mg nasal spray (2-count units) on June 18, 2025, with completion targeted for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under AmerisourceBergen's broader pharmaceutical supply infrastructure...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at fourteen thousand seven hundred twenty-seven dollars and seventy cents ($14,727.70) to Amerisourcebergen Drug Corporation for NARCAN 4 mg nasal spray kits. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two-day period concluding on September 8, 2023. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NARCAN (naloxone) 4 mg nasal spray. The contract has a firm fixed price of $5,736.51 and an ultimate completion date of September 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which enables the DLA to efficiently procure...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide NARCAN 4 mg nasal spray. The contract has a ceiling value of $8,522.14 and a performance period through March 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and runs through December...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQCWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,947.25 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (two-pack units) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Narcan (naloxone) is a critical emergency medication used to rapidly reverse opioid overdoses, making it an essential component of federal medical supply chains supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The company's selection reflects its established capability to meet federal procurement requirements and serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 9/4/25 |